CONTINUE FUNDING ALZHEIMER'S RESEARCH; Congressional Record Vol. 165, No. 86
(House of Representatives - May 22, 2019)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Page H4111]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                 CONTINUE FUNDING ALZHEIMER'S RESEARCH

  (Mr. VAN DREW asked and was given permission to address the House for 
1 minute and to revise and extend his remarks.)
  Mr. VAN DREW. Madam Speaker, right now, we face a health crisis.
  Alzheimer's disease is a degenerative brain disease and the most 
common form of dementia; 5.8 million Americans have this disease. One 
in three seniors dies with Alzheimer's. It is the sixth leading cause 
of death in the United States of America, and it kills more than breast 
cancer and prostate cancer combined.
  Nancy Reagan called the illness ``a truly long, long good-bye.''
  There are organizations and people working tirelessly on the research 
being done to fight and prevent these statistics from increasing, but 
they face three major roadblocks: soaring prevalence, lack of effective 
treatment, and enormous costs.
  The United States and the world face this crisis, and we must 
continue to support the funding of research for this incredibly 
devastating disease.
  Someday, we will win. Someday, there will be a cure.

                          ____________________